首页> Scientific reports> Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.

Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ahmed,Al-Darraji

第一单位： Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.

作者： Ahmed,Al-Darraji ^[1] ; Renée R,Donahue ^[1] ; Himi,Tripathi ^[1] ; Hsuan,Peng ^[1] ; Bryana M,Levitan ^[1] ; Lakshman,Chelvarajan ^[1] ; Dalia,Haydar ^[2] ; Erhe,Gao ^[3] ; David,Henson ^[2] ; John C,Gensel ^[4] ; David J,Feola ^[2] ; Vincent J,Venditto ^[2] ; Ahmed,Abdel-Latif ^[5]

作者单位： Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA. ^[1] College of Pharmacy, University of Kentucky, Lexington, KY, USA. ^[2] The Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA, USA. ^[3] Spinal Cord and Brain Injury Research Center, Department of Physiology, College of Medicine, University of Kentucky, Lexington, USA. ^[4] Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA. abdel-latif@uky.edu.;Division of Cardiology, University of Kentucky and the Lexington VAMC, 741 S. Limestone Street, BBSRB, Room 349, Lexington, KY, 40536-0509, USA. abdel-latif@uky.edu. ^[5]

DOI 10.1038/s41598-021-85720-6

PMID 33731792

发布时间 2023-09-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交